Addentax Group Corp. has announced a significant financial move by entering into a private placement agreement aimed at raising approximately $1.5 million. The company will issue 312,500 shares of its common stock at a price of $4.80 per share. This funding is intended for general corporate purposes, including working capital and potential strategic investments.
The private placement agreement was made with Mr. Chan Kai Fung, who is identified as the investor. The transaction is subject to customary closing conditions, which must be satisfied or waived before the deal is finalized.
According to the filing, the shares issued will rely on exemptions from the registration requirements of the Securities Act of 1933, specifically under Regulation S. This means that the shares will not be registered and cannot be sold in the United States unless they meet certain regulatory criteria.
Background
Addentax Group Corp. operates in the services sector, specifically within the mailing, reproduction, commercial art, and photography industry, classified under SIC 7330. The company is publicly traded on the Nasdaq under the ticker ATXG and is categorized as a smaller reporting company. Recently, the company has been active in filing various forms, including multiple 8-Ks and Schedule 13G filings.
What the Filing Says
The filing indicates, "On November 5, 2026, Addentax Group Corp. entered into a private placement agreement... for aggregate gross proceeds of approximately $1.5 million." It further notes that the company intends to use the net proceeds for general corporate purposes.
Impact
This private placement may significantly impact the company's financial standing, enabling it to enhance its working capital and pursue strategic investments. Investors and stakeholders in the mailing and reproduction services industry may view this move as a positive sign of financial health and growth potential.
What's Next
The filing does not specify what happens next, but the completion of the private placement is contingent upon the satisfaction of customary closing conditions.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










